Wang, Junpeng <br/><br/>
Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets.  [electronic resource] 

 -  The American journal of pathology  Jan 2012 
 - 221-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1525-2191 
<br/><br/><label>Standard No.: </label>10.1016/j.ajpath.2011.09.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD4-Positive T-Lymphocytes--drug effects<br/>Catechin--analogs & derivatives<br/>Cell Proliferation<br/>Cytokines--metabolism<br/>Demyelinating Diseases--prevention & control<br/>Dietary Supplements<br/>Down-Regulation<br/>Encephalomyelitis, Autoimmune, Experimental--immunology<br/>Female<br/>Mice<br/>Mice, Inbred C57BL<br/>Monocytes--metabolism<br/>Multiple Sclerosis--immunology<br/>Myelin Proteins--antagonists & inhibitors<br/>Myelin-Oligodendrocyte Glycoprotein<br/>Neuritis--prevention & control<br/>Neuroprotective Agents--pharmacology<br/>Nuclear Receptor Subfamily 1, Group F, Member 3--antagonists & inhibitors<br/>Random Allocation<br/>T-Box Domain Proteins--antagonists & inhibitors<br/>T-Lymphocyte Subsets--drug effects<br/>T-bet Transcription Factor